Skip to main content

Mangoceuticals, Inc.

corporate_fare Company Profile

Mangoceuticals, Inc.

MGRX·NASDAQ·Industrial Applications And Services·CIK 0001938046

Mangoceuticals, Inc. develops, markets, and sells men's wellness products and services in the United States, primarily through a telemedicine platform. The company offers erectile dysfunction products under the Mango brand, hair loss products under the Grow brand, hormone balance and therapy products under the Mojo brand, and weight loss products under the Slim brand. It also provides oral testosterone undecanoate, marketed under the Prime brand, to treat low testosterone in men and for testosterone replacement therapy. Mangoceuticals facilitates customer access to a licensed pharmacy for online fulfillment and distribution of medications prescribed during telehealth consultations. The company markets and sells its products online via its website, www.MangoRX.com. Incorporated in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as a subsidiary of Cohen Enterprises, Inc.

Mangoceuticals, Inc. (NASDAQ:MGRX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for MGRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 10 rated 8 or above. Recent SEC coverage for MGRX spans 10-Q, 8-K, PRE 14A, 424B5.

Recent high-impact activity:

  • Mangoceuticals Q3 10-Q: $8.3M Nine-Month Loss, $659K Cash, Going Concern Doubt
  • Mangoceuticals Sets Series D Terms: $15 Liquidation Preference, 8% Cash Dividends, 3-Year Conversion Lock
  • Mangoceuticals Seeks Up to $10M in Tokenized 8% Preferred Stock Sale
  • Mangoceuticals Clears Path for Up to $10M Series D Preferred Offering
  • Mangoceuticals Seeks 1-for-2 to 1-for-25 Reverse Split to Hold Nasdaq Listing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$456.02K
Net Income
-$20.64M
Diluted EPS
-$2.17
Op. Cash Flow
-$5.85M
Gross Profit
$250.39K
Operating Income
-$18.03M
Cash & Equivalents
$1.49M
Debt / Equity
0.00×
Net Margin
-45.27×
Shares Outstanding
15.89M sh
Source: 10-K · filed 2026-04-01 · accession 0001493152-26-014478

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 53,343 shares in MGRX as of the October 30, 2026 settlement, a 41.7% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 5.4% of MGRX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)53,343 shares as of October 30, 2026
Change vs prior period▼ 41.7%
Days to cover1.00 at avg daily volume of 369,429
Daily short volume (FINRA facilities)5.4% of 103,419 shares on November 20, 2026
5-day average short volume18.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for MGRX, detected from its recent SEC filings · based on capital-structure filings through 2026-10-09.

1 recent capital raise

Registered Direct Offering Priced · Warrant Terms

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with M →
$0.124 +0.32% today
52-week range · as of 2026-11-16 $0.124 – $1.49
Market cap
$2.75M
Volume
241.3K (0.3× avg)
3-mo avg 711.6K
Live data · 2026-11-22 12:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MGRX - Latest Insights

MGRX
Nov 16, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1615
Real-time Price: $0.124 info
Change: -$0.0375 (-23%) info
Market Cap: $2.747M info
MGRX
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.155
Real-time Price: $0.124 info
Change: -$0.031 (-20%) info
Market Cap: $2.747M info
MGRX
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.2078
Real-time Price: $0.124 info
Change: -$0.0838 (-40%) info
Market Cap: $2.747M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.124 info
Change: -$0.066 (-35%) info
Market Cap: $2.747M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.124 info
Change: -$0.066 (-35%) info
Market Cap: $2.747M info
MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.124 info
Change: -$0.306 (-71%) info
Market Cap: $2.747M info
MGRX
Oct 09, 2026, 4:00 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4251
Real-time Price: $0.124 info
Change: -$0.3011 (-71%) info
Market Cap: $2.747M info
MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.124 info
Change: -$0.2867 (-70%) info
Market Cap: $2.747M info
MGRX
Oct 01, 2026, 3:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4921
Real-time Price: $0.124 info
Change: -$0.3681 (-75%) info
Market Cap: $2.747M info
MGRX
Aug 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.124 info
Change: -$0.2781 (-69%) info
Market Cap: $2.747M info
MGRX
Aug 13, 2026, 5:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.625
Real-time Price: $0.124 info
Change: -$0.501 (-80%) info
Market Cap: $2.747M info
MGRX
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7485
Real-time Price: $0.124 info
Change: -$0.6245 (-83%) info
Market Cap: $2.747M info
MGRX
Aug 05, 2026, 6:13 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $0.5363
Real-time Price: $0.124 info
Change: -$0.4123 (-77%) info
Market Cap: $2.747M info
MGRX
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.441
Real-time Price: $0.124 info
Change: -$0.317 (-72%) info
Market Cap: $2.747M info
MGRX
Jul 30, 2026, 10:35 AM EDT
Source: TMX Newsfile
Importance Score:
9
Price at Filing: $0.3789
Real-time Price: $0.124 info
Change: -$0.2549 (-67%) info
Market Cap: $2.747M info
MGRX
Jul 30, 2026, 7:01 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $0.540
Real-time Price: $0.124 info
Change: -$0.416 (-77%) info
Market Cap: $2.747M info
MGRX
Jul 30, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.540
Real-time Price: $0.124 info
Change: -$0.416 (-77%) info
Market Cap: $2.747M info
MGRX
Jul 02, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4555
Real-time Price: $0.124 info
Change: -$0.3315 (-73%) info
Market Cap: $2.747M info
MGRX
May 19, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4299
Real-time Price: $0.124 info
Change: -$0.3059 (-71%) info
Market Cap: $2.747M info
MGRX
Apr 01, 2026, 6:31 AM EDT
Filing Type: 10-K
Importance Score:
10
Price at Filing: $0.3622
Real-time Price: $0.124 info
Change: -$0.2382 (-66%) info
Market Cap: $2.747M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets